BTK and B-cell chronic lymphocytic leukemia: It is likely that the inhibition of BCR signaling by BTK or PI3K inhibition leads to upregulation of FoxO1 mRNA in CLL cells because its transcription is not repressed by the “continuous” tonic BCR signaling.